Do you have some extra fullness beneath your chin? Maybe it’s something you’ve had your whole life, something that developed over the years, or something you noticed recently. This is a condition called submental fullness, which some people refer to as “double chin.”
Give us a call TODAY at 614-334-4944 and schedule your consultation to discuss how Kybella can help you!
About the procedure*
What is Kybella?
KYBELLA® is the only FDA-approved injectable treatment that destroys fat cells under the chin to improve your profile.
How does Kybella work?
The active ingredient in KYBELLA® is synthetic deoxycholic acid. Deoxycholic acid is a naturally occurring molecule in the body that aids in the breakdown and absorption of dietary fat. When injected into the fat beneath the chin, KYBELLA® destroys fat cells, resulting in a noticeable reduction in fullness under the chin. Once destroyed, these cells can no longer store or accumulate fat, so further treatment is not expected once you reach your desired aesthetic goal.
Who is a good candidate for Kybella?
KYBELLA® may be right for you if:
- You’re bothered (unhappy, self-conscious, embarrassed) by fat under the chin, also known as submental fullness.
- You feel the condition makes you look older or heavier than you actually are.
- You don’t want to have surgery.
- You eat well and exercise, but submental fullness does not go away.
WHAT CAN I EXPECT WITH KYBELLA®?
Before starting treatment, your healthcare specialist will examine the area under and around your chin to determine if KYBELLA® is right for you. Then, your specialist will tailor your treatment to the amount of fat under the chin and your aesthetic goals.
How is KYBELLA® administered?
Treatment can only be administered by a KYBELLA®-trained healthcare specialist. At each treatment, you will receive multiple small injections under your chin, and the injection process takes about 15 to 20 minutes. The exact number of injections will depend on the amount of fat you have under your chin and your desired profile.
What are the possible side effects of KYBELLA®?
The most common side effects occur in the treatment area and include: Swelling, bruising, pain, numbness, redness, or areas of hardness. Side effects are usually temporary and often resolve on their own.
How many treatments will I need?
Your specialist will create a tailored treatment plan based on your chin profile. At each treatment, you will be given multiple small injections under your chin. You may receive up to 6 treatment sessions, spaced at least 1 month apart. Many patients experience visible results in 2 to 4 KYBELLA® treatments
How can I save on treatments?
Enroll in the Brilliant Distinctions® Rewards Program to save money on KYBELLA treatments. You earn points on each KYBELLA treatment that you can redeem for savings on future treatments. You can also earn and redeem points on other selected treatments that your specialist may determine are right for you.
In addition, you can also earn points when you shop online at your favorite retailers participating in the Brilliant Distinctions® Mall. As a member you will receive treatment reminders and information about your points balance. Enroll in Brilliant Distinctions here.
Important Safety Information
KYBELLA® (deoxycholic acid) injection is indicated for improvement in the appearance of moderate to severe convexity or fullness associated with submental fat in adults. The safe and effective use of KYBELLA® for the treatment of subcutaneous fat outside the submental region has not been established and is not recommended.
Important Safety Information
KYBELLA® is contraindicated in the presence of infection at the injection sites.
Warnings and Precautions
Marginal Mandibular Nerve Injury
Cases of marginal mandibular nerve injury, manifested as an asymmetric smile or facial muscle weakness, were reported in 4% of subjects in the clinical trials; all cases resolved spontaneously (range 1-298 days, median 44 days). KYBELLA® should not be injected into or in close proximity to the marginal mandibular branch of the facial nerve.
Dysphagia occurred in 2% of subjects in the clinical trials in the setting of administration-site reactions, eg, pain, swelling, and induration of the submental area; all cases of dysphagia resolved spontaneously (range 1-81 days, median 3 days). Avoid use of KYBELLA® in patients with current or prior history of dysphagia as treatment may exacerbate the condition.
In clinical trials, 72% of subjects treated with KYBELLA® experienced hematoma/bruising. KYBELLA® should be used with caution in patients with bleeding abnormalities or who are currently being treated with antiplatelet or anticoagulant therapy as excessive bleeding or bruising in the treatment area may occur.
Risk of Injecting Into or in Proximity to Vulnerable Anatomic Structures
To avoid the potential of tissue damage, KYBELLA® should not be injected into or in close proximity (1 cm-1.5 cm) to salivary glands, lymph nodes, and muscles.
The most commonly reported adverse reactions in the pivotal clinical trials were:
- injection site edema/swelling
Please see KYBELLA® full prescribing information.
To download pdf click here
*Treatment results depicted or described may vary by individual and are not guaranteed.